ANA Therapeutics Announces U.S. FDA Clearance Of IND Application To Initiate Clinical Trial Of Niclosamide In COVID-19 Patients

ANA Therapeutics Announces U.S. FDA Clearance Of IND Application To 
Initiate Clinical Trial Of Niclosamide In COVID-19 Patients
Article by
Article Date
August 9, 2023
Category
Portfolio